Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling

• Asıl Yazarlar: Karthick Harini (Yazar), Suliman Yousef Alomar (Yazar), Mohammed Vajagathali (Yazar), Salim Manoharadas (Yazar), Anbazhagan Thirumalai (Yazar), Koyeli Girigoswami (Yazar), Agnishwar Girigoswami (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2024-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Bupropion (Bup) belongs to the norepinephrine-dopamine reuptake inhibitor (NDRI) class and it is the only FDA-approved drug of its class for the treatment of major depressive disorder (MDD), sold under the name of Wellbutrin. Although bupropion is effective in suppressing the symptoms, its regular u...